The ILEUS Study: A Phase 2 Randomized Controlled Trial Investigating Alvimopan for Enhanced Gastrointestinal Recovery After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 11 May 2018
At a glance
- Drugs Alvimopan (Primary)
- Indications Postoperative ileus
- Focus Therapeutic Use
- Acronyms ILEUS
- 02 May 2018 Planned End Date changed from 1 Dec 2019 to 1 Mar 2021.
- 02 May 2018 Planned primary completion date changed from 1 Dec 2019 to 1 Mar 2020.
- 02 May 2018 Status changed from not yet recruiting to recruiting.